Sermorelin 5mg
GHRH (1‑29) Analog • Lyophilized Peptide • Research Use Only
Description: Sermorelin is a synthetic peptide analog of Growth Hormone‑Releasing Hormone (GHRH 1‑29)—the biologically active fragment responsible for stimulating endogenous growth hormone (GH) secretion. It is widely studied for its ability to activate the pituitary GH axis, supporting research into muscle growth, recovery, metabolic function, and anti‑aging pathways.
Sermorelin is frequently explored alongside other GH secretagogues such as Ipamorelin or CJC‑1295, where synergistic effects on GH release and IGF‑1 signaling are of particular interest.
Peptide: Sermorelin (GHRH 1‑29)
Purity: ≥99.8%
Form: Lyophilized powder
Quantity: 5mg per vial
Storage:
Store at –20°C (–4°F)
After reconstitution, refrigerate at 2–8°C (36–46°F); use within 30 days
Grade: Research Use Only — Not for human consumption, therapeutic, or diagnostic use
Growth hormone stimulation and pituitary‑axis activation
Muscle growth, recovery, and tissue‑repair models
Anti‑aging and longevity‑related GH studies
Endocrine function and GH/IGF‑1 pathway exploration
Metabolic health and body‑composition research
Sermorelin is studied for its ability to:
Stimulate endogenous GH release via GHRH receptor activation
Support IGF‑1 production and anabolic signaling
Influence sleep‑related GH pulses
Enhance recovery, tissue repair, and metabolic function
Provide a physiological GH‑axis activation model compared to exogenous GH
Its targeted action on the pituitary makes Sermorelin a foundational peptide in growth hormone, endocrine, and regenerative‑biology research.
FOR LABORATORY RESEARCH USE ONLY. NOT FOR HUMAN CONSUMPTION.